Table of Contents
ISRN Neurology
Volume 2011, Article ID 947476, 3 pages
http://dx.doi.org/10.5402/2011/947476
Clinical Study

Initial Stroke Severity Is the Major Outcome Predictor for Patients Who Do Not Receive Intravenous Thrombolysis due to Mild or Rapidly Improving Symptoms

1Department of Neurology, Changhua Christian Hospital, Changhua 500, Taiwan
2Department of Emergency Medicine, Changhua Christian Hospital, Changhua 500, Taiwan

Received 6 May 2011; Accepted 5 June 2011

Academic Editors: A. Arboix, R. L. Macdonald, and A. K. Petridis

Copyright © 2011 Mu-Chien Sun and Tien-Bao Lai. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. P. Adams, G. del Zoppo, M. J. Alberts et al., “Guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups,” Stroke, vol. 38, no. 5, pp. 1655–1711, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. P. A. Barber, J. Zhang, A. M. Demchuk, M. D. Hill, and A. M. Buchan, “Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility,” Neurology, vol. 56, no. 8, pp. 1015–1020, 2001. View at Google Scholar · View at Scopus
  3. I. L. Katzan, M. D. Hammer, E. D. Hixson, A. J. Furlan, A. Abou-Chebl, and D. M. Nadzam, “Utilization of intravenous tissue plasminogen activator for acute ischemic stroke,” Archives of Neurology, vol. 61, no. 3, pp. 346–350, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. J. C. García-Moncó, A. Pinedo, I. Escalza et al., “Analysis of the reasons for exclusion from tPA therapy after early arrival in acute stroke patients,” Clinical Neurology and Neurosurgery, vol. 109, no. 1, pp. 50–53, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. E. E. Smith, A. R. Abdullah, I. Petkovska, E. Rosenthal, W. J. Koroshetz, and L. H. Schwamm, “Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke,” Stroke, vol. 36, no. 11, pp. 2497–2499, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. I. Hsieh, L. M. Lien, S. T. Chen et al., “Get with the guidelines-stroke performance indicators: surveillance of stroke care in the Taiwan stroke registry: get with the guidelines-stroke in Taiwan,” Circulation, vol. 122, no. 11, pp. 1116–1123, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group, “Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience,” Annals of Emergency Medicine, vol. 46, no. 3, pp. 243–252, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. Köhrmann, T. Nowe, H. B. Huttner et al., “Safety and outcome after thrombolysis in stroke patients with mild symptoms,” Cerebrovascular Diseases, vol. 27, no. 2, pp. 160–166, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Dirks, L. W. Niessen, P. J. Koudstaal, C. L. Franke, R. J. Van Oostenbrugge, and D. W.J. Dippel, “Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 7, pp. 685–689, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. C. R. Baumann, R. W. Baumgartner, J. Gandjour, H. -C. Von Büdingen, A. M. Siegel, and D. Georgiadis, “Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms,” Stroke, vol. 37, no. 5, pp. 1332–1333, 2006. View at Publisher · View at Google Scholar · View at PubMed